Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease.

Zanusso G, Fiorini M, Ferrari S, Gajofatto A, Cagnin A, Galassi A, Richelli S, Monaco S.

Int J Mol Sci. 2011;12(9):6281-92. doi: 10.3390/ijms12096281. Epub 2011 Sep 23.

2.

Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.

Baldeiras IE, Ribeiro MH, Pacheco P, Machado A, Santana I, Cunha L, Oliveira CR.

J Neurol. 2009 Sep;256(9):1540-50. doi: 10.1007/s00415-009-5160-0. Epub 2009 May 6.

PMID:
19418113
3.

The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review.

Chohan G, Pennington C, Mackenzie JM, Andrews M, Everington D, Will RG, Knight RS, Green AJ.

J Neurol Neurosurg Psychiatry. 2010 Nov;81(11):1243-8. doi: 10.1136/jnnp.2009.197962. Epub 2010 Sep 20.

PMID:
20855493
4.

Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.

Lattanzio F, Abu-Rumeileh S, Franceschini A, Kai H, Amore G, Poggiolini I, Rossi M, Baiardi S, McGuire L, Ladogana A, Pocchiari M, Green A, Capellari S, Parchi P.

Acta Neuropathol. 2017 Apr;133(4):559-578. doi: 10.1007/s00401-017-1683-0. Epub 2017 Feb 15.

5.

CSF Tau proteins reduce misdiagnosis of sporadic Creutzfeldt-Jakob disease suspected cases with inconclusive 14-3-3 result.

Leitão MJ, Baldeiras I, Almeida MR, Ribeiro MH, Santos AC, Ribeiro M, Tomás J, Rocha S, Santana I, Oliveira CR.

J Neurol. 2016 Sep;263(9):1847-61. doi: 10.1007/s00415-016-8209-x. Epub 2016 Jun 29.

PMID:
27357003
6.

Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.

Llorens F, Zafar S, Ansoleaga B, Shafiq M, Blanco R, Carmona M, Grau-Rivera O, Nos C, Gelpí E, Del Río JA, Zerr I, Ferrer I.

Neuropathol Appl Neurobiol. 2015 Aug;41(5):631-45. doi: 10.1111/nan.12175. Epub 2015 Apr 30.

PMID:
25134744
7.

Sporadic Creutzfeldt-Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay.

Leitão MJ, Baldeiras I, Almeida MR, Ribeiro MH, Santos AC, Ribeiro M, Tomás J, Rocha S, Santana I, Oliveira CR.

Neuroscience. 2016 May 13;322:398-407. doi: 10.1016/j.neuroscience.2016.02.057. Epub 2016 Mar 3.

PMID:
26940479
8.

The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease.

Bahl JM, Heegaard NH, Falkenhorst G, Laursen H, Høgenhaven H, Mølbak K, Jespersgaard C, Hougs L, Waldemar G, Johannsen P, Christiansen M.

Neurobiol Aging. 2009 Nov;30(11):1834-41. doi: 10.1016/j.neurobiolaging.2008.01.013. Epub 2008 Mar 12.

PMID:
18339451
9.

Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel.

Meiner Z, Kahana E, Baitcher F, Korczyn AD, Chapman J, Cohen OS, Milo R, Aharon-Perez J, Abramsky O, Gabizon R, Rosenmann H.

J Neurol. 2011 Feb;258(2):255-62. doi: 10.1007/s00415-010-5738-6. Epub 2010 Sep 9.

PMID:
20827556
10.

Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years.

Stoeck K, Sanchez-Juan P, Gawinecka J, Green A, Ladogana A, Pocchiari M, Sanchez-Valle R, Mitrova E, Sklaviadis T, Kulczycki J, Slivarichova D, Saiz A, Calero M, Knight R, Aguzzi A, Laplanche JL, Peoc'h K, Schelzke G, Karch A, van Duijn CM, Zerr I.

Brain. 2012 Oct;135(Pt 10):3051-61. doi: 10.1093/brain/aws238. Epub 2012 Sep 25.

11.
12.

Clinical findings and diagnostic tests in Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease.

Krasnianski A, Meissner B, Heinemann U, Zerr I.

Folia Neuropathol. 2004;42 Suppl B:24-38. Review.

PMID:
16903140
13.

Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study.

Coulthart MB, Jansen GH, Olsen E, Godal DL, Connolly T, Choi BC, Wang Z, Cashman NR.

BMC Neurol. 2011 Oct 27;11:133. doi: 10.1186/1471-2377-11-133.

14.

Phosphorylated tau in cerebrospinal fluid as a marker for Creutzfeldt-Jakob disease.

Van Everbroeck B, Green AJ, Vanmechelen E, Vanderstichele H, Pals P, Sanchez-Valle R, Corrales NC, Martin JJ, Cras P.

J Neurol Neurosurg Psychiatry. 2002 Jul;73(1):79-81.

15.

Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease.

Dorey A, Tholance Y, Vighetto A, Perret-Liaudet A, Lachman I, Krolak-Salmon P, Wagner U, Struyfs H, De Deyn PP, El-Moualij B, Zorzi W, Meyronet D, Streichenberger N, Engelborghs S, Kovacs GG, Quadrio I.

JAMA Neurol. 2015 Mar;72(3):267-75. doi: 10.1001/jamaneurol.2014.4068.

PMID:
25559883
16.

Quantification of CSF biomarkers using an electrochemiluminescence-based detection system in the differential diagnosis of AD and sCJD.

Llorens F, Kruse N, Schmitz M, Shafiq M, da Cunha JE, Gotzman N, Zafar S, Thune K, de Oliveira JR, Mollenhauer B, Zerr I.

J Neurol. 2015 Oct;262(10):2305-11. doi: 10.1007/s00415-015-7837-x. Epub 2015 Jul 11.

PMID:
26162713
17.

Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease.

Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A, Pocchiari M, Almonti S, Cuadrado-Corrales N, de Pedro-Cuesta J, Budka H, Gelpi E, Glatzel M, Tolnay M, Hewer E, Zerr I, Heinemann U, Kretszchmar HA, Jansen GH, Olsen E, Mitrova E, Alpérovitch A, Brandel JP, Mackenzie J, Murray K, Will RG.

Brain. 2006 Sep;129(Pt 9):2278-87. Epub 2006 Jul 1.

18.

Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.

Schmitz M, Lüllmann K, Zafar S, Ebert E, Wohlhage M, Oikonomou P, Schlomm M, Mitrova E, Beekes M, Zerr I.

Neurobiol Aging. 2014 May;35(5):1177-88. doi: 10.1016/j.neurobiolaging.2013.11.010. Epub 2013 Nov 16.

PMID:
24360565
19.

Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease.

Varges D, Jung K, Gawinecka J, Heinemann U, Schmitz M, von Ahsen N, Krasnianski A, Armstrong VW, Zerr I.

J Alzheimers Dis. 2011;23(4):717-26. doi: 10.3233/JAD-2010-101527.

PMID:
21157024
20.

The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease.

Pennington C, Chohan G, Mackenzie J, Andrews M, Will R, Knight R, Green A.

Neurosci Lett. 2009 May 8;455(1):56-9. doi: 10.1016/j.neulet.2009.02.067. Epub 2009 Mar 5.

PMID:
19429106

Supplemental Content

Support Center